AKI India Limited Overview
AKI India Limited is a Kanpur-based, family-promoted manufacturer and exporter of genuine leather and leather products whose origins lie in equestrian saddlery and harness goods made with technical assistance from a German horse-riding group. Over three decades it has layered on leather footwear (from 2007–08), an owned tannery at Unnao (acquired around 2010) producing finished and upholstery leather, leather accessories, pet accessories and trading in leather chemicals. The company is vertically integrated from hide to finished product but sub-scale: FY2026 consolidated revenue was INR 107.3 Cr. Its strategic pivot since 2023 has been to move closer to Western end-customers through a wholly owned UK subsidiary (AKI UK Limited) and an equity-accounted footwear joint venture (AKI Castil Shoes LLP, understood to be the vehicle for the announced partnership with UK bootmaker NPS Shoes, owner of the Solovair brand). Operating margins at the core business are currently negative; reported profit depends on other income and associate earnings.
Company's own description
The company's website and annual-report language describe AKI India as an ISO-certified public limited company primarily engaged in the design and manufacture of leather products for equestrian sports, horse covers (rugs), leather shoes, bags, belts, pet accessories, and all types of finished leather, with an emphasis on quality and craftsmanship in both domestic and international markets. Corporate regulatory filings describe the company as "primarily engaged in the business of manufacturing and trading of Leather and Leather Goods" and state that it operates in a single primary segment, Leather & Leather Goods, so Ind AS 108 segment reporting is not applied. The MCA classifies its main line of business as tanning and dressing of leather and manufacture of luggage, handbags, saddlery, harness and footwear.
The company's mission statement (website) emphasises premium quality, a blend of traditional technique and innovation, sustainability and ethical practices, and long-term customer relationships; its vision is to become a global leader in leather known for quality, design and sustainable practice.
Independent characterisation
AKI India is best understood as a small, export-oriented, vertically integrated leather converter with four economic engines:
-
Tannery (Unnao): Processes raw hides into finished leather and upholstery leather — both for captive consumption and for third-party sale. This is the base of the integration and the main source of the LWG Gold rating. Finished-leather sales are commodity-like and price-sensitive.
-
Equestrian and saddlery products (heritage line): Bridles, browbands, crown pieces, reins, head collars, halters, chaps and gaiters, saddle girths, driving harness, pony articles and horse rugs. These are low-volume, labour-intensive, design-led products sold predominantly to European, Australian and other equestrian markets, typically on a private-label or OEM basis.
-
Footwear: Formal, riding, deck/marine, casual and canvas shoes, countryside boots, and sandals/slippers. Historically export OEM; since 2023–24 the company has sought a branded/premium angle through the NPS Shoes (Solovair) partnership and a UK sales presence.
-
Accessories, pet products and trading: Leather bags, belts, wallets, dog collars, leads and covers, dog toys; plus domestic trading in leather chemicals and purchased stock-in-trade.
Business and revenue model
| Dimension | Assessment |
|---|---|
| Product vs. service vs. subscription vs. licensing mix | Essentially 100% product sales (manufactured goods plus traded goods). No subscription or licensing revenue disclosed. "Other income" (INR 10.94 Cr in FY2026, consolidated) is material relative to operating profit — its composition (export incentives, interest, forex gains, etc.) is not itemised in the sources reviewed. |
| Manufactured vs. traded | FY2026 standalone: cost of materials consumed INR 46.87 Cr; purchases of stock-in-trade INR 13.41 Cr, against standalone net sales of INR 64.71 Cr — indicating that roughly one-fifth of standalone sales by cost basis are traded goods. |
| Channel | Predominantly B2B: private-label/OEM supply to overseas importers, brand owners and wholesalers; intra-group sales to AKI UK Limited and AKI Castil Shoes LLP; domestic sales of finished leather and leather chemicals. The company had a retail foray from 2013 (branded basic footwear wholesale/distribution); current scale of retail is not disclosed. |
| Customer types | Overseas importers/distributors of equestrian goods and footwear; brand owners; bulk buyers and medium-scale wholesalers (per company marketplace listings); domestic tanneries/manufacturers (chemicals and finished leather). Named customers: not publicly disclosed. |
| End-markets | Equestrian sports and leisure riding; men's and women's leather footwear (formal, outdoor, country, marine); fashion accessories; pet accessories; upholstery leather (furniture/automotive end-use not specified). |
| Geographic markets | India, Europe (UK prominent), Australia, UAE and South Africa (company statement, October 2023). Exports were INR 37.81 Cr of FY2025 standalone revenue. |
| Value-chain position | Mid-stream to downstream: raw hide → finished leather (owned tannery) → finished goods (own factories) → wholesale/B2B. Does not own consumer brands of scale; branding ambitions run through the NPS/Solovair JV and the UK subsidiary. |
| Working-capital intensity | Very high. Cash conversion cycle widened from 114 days (FY2023) to 214 days (FY2026), driven by inventory days of 210 (Screener.in, consolidated). |
Strategy
Stated strategy
AKI India does not publish an investor-day presentation or medium-term targets. Its stated strategic themes, drawn from the website mission/vision, FY2025 Board's Report summaries and management statements around the October 2023 fundraise, are:
-
Premiumisation and quality leadership — combining traditional craftsmanship with modern methods; LWG Gold and ISO certifications as differentiators.
-
Sustainability and ethical production — "green initiative," LWG Gold rating, and a stated FY2025 focus on sustainable leather production.
-
Market expansion — broadening international reach, particularly the UK/Europe.
-
Inflection-point capital raising — the founder characterised the company as at an "inflexion point" in October 2023 and positioned the INR 80 Cr fundraise as the means to reach a new scale.
-
Partnership-led branded growth — the NPS Shoes JV to bring Solovair to India and co-manufacture/export.
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Status |
|---|---|---|---|
| Warrant conversion (INR 80 Cr programme, second leg) | May–Jun 2025 | Second and third tranches of consideration received (15 and 24 May 2025); 1,46,73,782 of 1,74,41,782 warrants converted on 9 Jun 2025 | Completed for 84% of warrants; status of remaining 27,68,000 warrants not disclosed (likely lapsed after 18-month window) |
| AKI Castil Shoes LLP ramp-up | FY2025–FY2027 | Footwear JV at Unnao; share of associate profit rose to INR 0.45 Cr in Q1 FY2027 from INR 0.02 Cr | Operating; scale undisclosed |
| AKI UK Limited scale-up | FY2026–FY2027 | Material RPT envelope of ≈INR 30 Cr with AKI UK approved by board (1 Sep 2026) and AGM (23 Sep 2026) | Ongoing |
| Governance reconstitution | Jan–Jul 2026 | Three board/committee reconstitutions; internal auditor appointed for FY2027 | Completed (see Section 9) |
| Capacity expansion | FY2025 | Board's Report summaries cite expanded capacity and improved inventory management; CWIP INR 10 Cr at Mar 2026 | Not quantified |
| Sustainability | Ongoing | LWG Gold; ISO 14001; CSR and green-initiative pages | Ongoing |
Cost programmes / transformation programmes with targets: None disclosed.
Management guidance
No quantitative guidance (revenue, margin or capex) has been issued. There are no earnings calls. Consensus estimates do not exist.
Products & Services
The company's website organises products under six main categories. No pricing, launch dates or volumes are disclosed for any product; the company sells predominantly on a made-to-order/OEM basis with customisation capability.
Equestrian Products (heritage line, since 1994)
| Product | Description / capabilities | Target customer | Pricing model |
|---|---|---|---|
| Bridles | Leather headgear for horse control; English-style designs | Equestrian importers, tack shops (Europe, Australia) | OEM/order-based; not disclosed |
| Browbands | Decorative/functional bridle strap across horse's forehead | Same | — |
| Crown pieces | Bridle headpiece components | Same | — |
| Reins | Leather (and combination) reins | Same | — |
| Head collars / halters | Stable and turnout headwear | Same | — |
| Chaps and gaiters | Rider leg protection | Riders via distributors | — |
| Saddle girths | Saddle-securing straps | Equestrian distributors | — |
| Driving harness | Harness sets for carriage driving | Specialist driving-sport distributors | — |
| Pony articles | Scaled tack for ponies | Equestrian distributors | — |
| Horse rugs / covers | Turnout and stable rugs | Equestrian distributors | — |
| Miscellaneous saddlery | Other leather saddlery & harness goods | Equestrian distributors | — |
Leather Footwear (since FY2008)
| Product | Description | Target customer |
|---|---|---|
| Formal shoes (men's/women's) | Leather dress footwear | Overseas brand owners/importers; domestic trade |
| Riding footwear | Equestrian riding boots/shoes | Equestrian channel |
| Deck / marine shoes | Boat-shoe style | Overseas importers |
| Casual shoes; canvas shoes | Leisure footwear | Overseas/domestic |
| Countryside boots | Outdoor/country-style boots (relevant to UK market) | UK/European importers |
| Outdoor footwear | Rugged footwear | Overseas importers |
| Slippers and sandals | Open footwear | Domestic/overseas |
| Solovair-branded shoes (via JV, planned) | Goodyear-welted British heritage footwear from NPS Shoes, to be introduced in India and made/exported via the JV | Premium Indian and global consumers |
Note: The Solovair introduction was announced in October 2023; actual Indian launch status, volumes and pricing are not publicly disclosed.
Leather Accessories
| Product | Description | Target customer |
|---|---|---|
| Leather bags | Fashion and utility bags | Importers, wholesalers |
| Belts | Men's/women's leather belts | Importers, wholesalers |
| Wallets | Small leather goods | Importers, wholesalers |
Pet Accessories
| Product | Description | Target customer |
|---|---|---|
| Dog collars | Leather collars | Pet-product importers |
| Leads | Leather leashes | Pet-product importers |
| Dog covers | Coats/covers | Pet-product importers |
| Dog toys | Leather/other toys | Pet-product importers |
Finished Leather (Unnao tannery)
| Product | Description | Target customer |
|---|---|---|
| Finished leather (all types) | Processed from raw hides; for footwear, bags, belts, harness | Captive use; domestic and export manufacturers |
| Harness leather | Heavy leathers for saddlery/harness | Captive; equestrian manufacturers |
| Upholstery leather | For furniture/upholstery | Upholstery manufacturers |
| Bag, belt and footwear leather | Category-specific finished leathers | Leather-goods makers |
Chemicals
| Product | Description | Target customer |
|---|---|---|
| Leather chemicals (trading) | Domestic trading in tanning/finishing chemicals | Tanneries in the Kanpur–Unnao cluster |
Flagship offerings
The company does not designate flagship SKUs. On the basis of heritage and certifications, the equestrian saddlery range and LWG Gold-rated finished leather are its most differentiated offerings; the Solovair partnership is the intended flagship of its branded-footwear ambitions.
Financial Narrative
Basis: Consolidated. FY2022–FY2023 from Screener.in (rounded to INR 1 Cr except where filings give precise values, e.g., FY2023 PAT of INR 1.16 Cr per FY2023 Annual Report). FY2024 from quarterly filings and FY2025 comparatives. FY2025–FY2026 from audited results filed 15 May 2026 and FY2025 Board's Report. Where sources conflict, both are noted.
Income statement
Gross profit: Not publicly disclosed on a consistent basis. An aggregator (Craft) cites Q3 FY2026 gross profit of INR 7.21 Cr on revenue of INR 25.56 Cr (≈28%), which cannot be verified from primary filings.
Revenue CAGR: FY2022–FY2026 ≈ 15.2% (61 → 107.33); FY2023–FY2026 ≈ 15.3%. Screener.in cites 3-year sales CAGR of 15% and TTM growth of 52%.
Commentary — P&L trends and drivers. The defining feature of AKI India's recent P&L is a deterioration in core operating economics masked by rising other income. Operating EBITDA (before other income) fell from a peak of ≈INR 2.9 Cr (4.1% margin) in FY2023 to a loss of INR 3.31 Cr (-3.1%) in FY2026, even as revenue grew 53%. Over the same period other income more than tripled to INR 10.94 Cr — exceeding the entire reported PBT four times over. Every quarter from Q1 FY2026 through Q1 FY2027 except Q2 FY2026 shows negative operating profit (Q3 FY2026 OPM -6.6%, Q4 FY2026 -3.9%). The likely drivers are: (i) pricing pressure in export markets after the US imposed a 50% tariff on Indian goods from 27 August 2025; (ii) a mix shift toward lower-margin traded goods and intra-group sales; (iii) under-absorption at the standalone level, where sales fell; and (iv) cost of scaling the UK subsidiary. The composition of other income is not itemised publicly — if it is dominated by export incentives (e.g., RoDTEP/duty drawback) or forex gains, it is a legitimate part of export economics; if it reflects interest on inter-corporate deposits or one-offs, earnings quality is weaker. Finance costs have been stable at ≈INR 1.8–2.1 Cr.
Quarterly trajectory (consolidated)
Source: Quarterly results via Screener.in; Q1 FY2027 per results filed 11 August 2026 (consolidated revenue INR 29.04 Cr vs INR 17.66 Cr, +64.4% YoY; PAT INR 0.51 Cr vs INR 0.23 Cr; share of profit from associates/JV INR 0.45 Cr vs INR 0.02 Cr).
Q1 FY2027 is notable: consolidated PAT of INR 0.51 Cr included INR 0.45 Cr of associate/JV profit — i.e., nearly 90% of group profit came from equity-accounted earnings. Standalone PAT fell 28.6% YoY to INR 0.15 Cr after an exceptional charge of INR 0.07 Cr, on standalone net sales of INR 18.68 Cr (+64.4% YoY but -13.8% QoQ).
Balance sheet
Notes: Short-term vs. long-term debt split is not publicly disclosed in the sources reviewed; CRISIL's facility list (INR 6 Cr term loan; INR 18.4 Cr packing credit, post-shipment credit, export funding and foreign LC limits; INR 0.1 Cr cash credit) indicates the borrowing base is predominantly short-term export credit. Goodwill & intangibles: not separately disclosed; presumed immaterial. FY2025 standalone current assets are derived (total assets INR 110.09 Cr less non-current assets, approximated); treat as indicative.
Commentary — balance sheet. The balance sheet was transformed by the January 2024 preferential issue and the June 2025 warrant conversion, which lifted consolidated equity from ≈INR 15 Cr (FY2023) to INR 100.3 Cr (FY2026) and cut gearing from ≈2.0x to 0.27x. However, the new capital has been absorbed almost entirely into working capital rather than productive fixed assets: net fixed assets are unchanged at ≈INR 14 Cr over five years, CWIP has crept up to INR 10 Cr (with no disclosed commissioning timeline), and "other assets" (inventories, receivables, loans and advances) have tripled from INR 42 Cr to INR 135 Cr. With borrowings again rising (INR 18 Cr → INR 27 Cr since FY2024), the company is re-leveraging to fund inventory.
Cash flow
Sources: Screener.in consolidated cash flows; FY2026 standalone CFO was -INR 20.26 Cr and standalone financing inflow INR 22.81 Cr (audited results). Capex derived as FCF minus CFO.
Commentary — cash flow. Cumulative free cash flow over FY2024–FY2026 was approximately -INR 49 Cr, against cumulative reported PAT of ≈INR 5 Cr. The company is funding its growth entirely from equity raises and incremental debt. FY2024's investing outflow of INR 18 Cr (versus capex of ≈INR 5 Cr) implies ≈INR 13 Cr of non-capex investing outflows (e.g., loans, deposits or investments) in the year of the preferential issue — the composition is not disclosed in the sources reviewed and warrants scrutiny.
Ratios
Other: Current ratio 3.43 (Upstox, latest); ROIC not separately computable from public data — ROCE used as proxy; net debt/operating EBITDA is not meaningful (negative EBITDA) for FY2025–FY2026. FY2022 ROE/ROA use rounded data and closing balances and should be treated as indicative only.
Commentary — ratios. Returns have collapsed as equity was multiplied six-fold without a commensurate rise in earnings: ROE has fallen from high single digits to ≈2.3%, well below the cost of capital (Screener notes a three-year average ROE of 2.1%). The cash conversion cycle has almost doubled in three years to 214 days, driven by inventory days rising from 129 to 210 and payable days compressing from 136 to 102 — the latter suggesting suppliers have tightened terms or the company is paying faster for raw hides. Interest coverage of ≈2.3x is adequate only because other income is counted; on operating EBITDA alone, coverage is negative.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Accounting | Country | Notes |
|---|---|---|---|---|
AKI India Limited | Parent / listed entity | — | India | Manufacturing (Unnao), corporate office (Kanpur) |
AKI UK Limited | Wholly owned subsidiary | Fully consolidated | United Kingdom | UK sales/distribution arm; Q1 FY2027 branch-auditor review reflected group share of total assets of GBP 413,396 and revenue of GBP 256,869 |
AKI Castil Shoes LLP | Joint venture / associate | Equity method | India (Unnao) | Incorporated 14 Mar 2024; footwear manufacturing/export; stake not disclosed in sources reviewed. Analyst inference: this is the vehicle for the October 2023 NPS Shoes JV (NPS MD Christian Castle; GST records list a partner named Christian James Edward) — unconfirmed by the company |
Segment (consolidated revenue from operations, INR Cr)
| Segment (consolidated revenue from operations, INR Cr) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Leather & Leather Goods | 70.92 | 80.96 | 107.33 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Segment metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Segment YoY revenue growth (%) | 1.3 | 14.2 | 32.6 |
Contribution to total revenue (%) | 100 | 100 | 100 |
Segment pre-tax income, reported consolidated PBT (INR Cr) | 1.89 | 2.67 | 2.71 |
Segment PBT margin (%) | 2.66 | 3.30 | 2.52 |
Revenue by entity (INR Cr)
| Revenue by entity (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Standalone net sales (AKI India Ltd) | 68.66 | 64.71 |
Consolidated revenue from operations | 80.96 | 107.33 |
Implied contribution of subsidiary net of eliminations | 12.30 | 42.62 |
Profit by entity (INR Cr)
| Profit by entity (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Standalone PAT | 1.63 | 1.44 |
Consolidated PAT | 1.68 | 1.93 |
Implied non-standalone PAT contribution | 0.05 | 0.49 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 61 | 70 | 70.92 | 80.96 | 107.33 |
Operating EBITDA excl. other income (INR Cr) | 2.32 | 2.87 | 2.35 | -0.15 | -3.31 |
Other income (INR Cr) | 3 | 3 | 3.22 | 6.52 | 10.94 |
EBITDA incl. other income (INR Cr) | 5.32 | 5.87 | 5.57 | 6.37 | 7.63 |
Depreciation & amortisation (INR Cr) | 2 | 2 | 1.85 | 1.81 | 2.03 |
Finance costs (INR Cr) | 1 | 2 | 1.83 | 1.89 | 2.12 |
Profit before tax, reported (INR Cr) | 2 | 2 | 1.89 | 2.67 | 2.71 |
Net profit after tax (INR Cr) | 2 | 1.16 | 1.37 | 1.68 | 1.93 |
EPS basic (INR) | 0.25 | 0.17 | 0.16 | 0.19 | 0.19 |
EPS diluted (INR) | 0.25 | 0.17 | 0.16 | 0.19 | 0.19 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin metric (%)
| Margin metric (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating EBITDA margin (%) | 3.8 | 4.1 | 3.31 | -0.19 | -3.08 |
EBITDA margin incl. other income (%) | 8.72 | 8.39 | 7.85 | 7.87 | 7.11 |
PBT margin (%) | 3.28 | 2.86 | 2.66 | 3.30 | 2.52 |
Net margin (%) | 3.28 | 1.66 | 1.93 | 2.08 | 1.80 |
Income Statement and Per-Share Data (Quarterly)
| Quarterly metric (INR Cr) | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 |
|---|---|---|---|---|---|
Revenue from operations | 17.66 | 27.52 | 25.56 | 36.58 | 29.04 |
Operating profit | -0.67 | 0.46 | -1.69 | -1.41 | -0.03 |
Other income | 1.98 | 1.40 | 3.93 | 3.63 | 1.73 |
PBT | 0.33 | 0.81 | 1.21 | 1.13 | 0.73 |
Net profit | 0.23 | 0.62 | 1.09 | 0.76 | 0.51 |
EPS (INR) | 0.02 | 0.06 | 0.11 | 0.07 | 0.05 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 60 | 63 | 104 | 114.37 | 160.14 |
Equity share capital (INR Cr) | 10 | 13 | 17 | 17.71 | 20.64 |
Other equity / reserves (INR Cr) | 4 | 2 | 43 | 47.43 | 79.68 |
Total equity (INR Cr) | 14 | 15 | 60 | 65.14 | 100.32 |
Total borrowings (INR Cr) | 29 | 30 | 18 | 22 | 27 |
Fixed assets, net (INR Cr) | 14 | 12 | 13 | 12 | 14 |
Capital work-in-progress (INR Cr) | 3 | 4 | 7 | 9 | 10 |
Investments (INR Cr) | 2 | 1 | 1 | 1 | 2 |
Other assets incl. current assets (INR Cr) | 42 | 46 | 83 | 93 | 135 |
Other liabilities (INR Cr) | 17 | 19 | 26 | 27 | 33 |
Working capital proxy: other assets less other liabilities (INR Cr) | 25 | 27 | 57 | 66 | 102 |
Balance Sheet (FY2025–FY2026)
| Liquidity metric (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Cash & cash equivalents, consolidated | 2.78 | 4.69 |
Net debt (borrowings less cash) | 19.22 | 22.31 |
Standalone cash & cash equivalents | 2.36 | 1.69 |
Standalone current assets | 85.00 | 101.92 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | 1 | 2 | -18 | -3 | -16 |
Capital expenditure (INR Cr) | -1 | -2 | -5 | -2 | -5 |
Free cash flow (INR Cr) | 0 | 0 | -23 | -5 | -21 |
Cash from investing activities (INR Cr) | -1 | -1 | -18 | -2 | -5 |
Cash from financing activities (INR Cr) | 0 | -1 | 36 | 5 | 23 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Return on equity (%, avg equity; FY2022 on closing) | 14.3 | 8.0 | 3.65 | 2.69 | 2.33 |
Return on assets (%, avg assets; FY2022 on closing) | 3.33 | 1.89 | 1.64 | 1.54 | 1.41 |
ROCE (%, Screener; FY2022 computed) | 7.0 | 8 | 6 | 5 | 4 |
Debt to equity (x) | 2.07 | 2.00 | 0.30 | 0.34 | 0.27 |
Interest coverage, (PBT+interest)/interest (x) | 3.0 | 2.0 | 2.03 | 2.41 | 2.28 |
Asset turnover (x) | 1.02 | 1.14 | 0.85 | 0.74 | 0.78 |
Debtor days | 106 | 103 | 109 | 129 | 105 |
Inventory days | 132 | 129 | 179 | 170 | 210 |
Payable days | 124 | 118 | 136 | 125 | 102 |
Cash conversion cycle (days) | 114 | 114 | 151 | 173 | 214 |
Leverage ratio
| Leverage ratio | FY2025 | FY2026 |
|---|---|---|
Net debt / EBITDA incl. other income (x) | 3.02 | 2.92 |
Region (Standalone Revenue, INR Cr) Overview
| Region (standalone revenue, INR Cr) | FY2025 |
|---|---|
Export earnings | 37.81 |
Domestic (derived: standalone net sales less exports) | 30.85 |
Export share of standalone net sales (%) | 55.1 |
Region Overview
| Region | Direction | Evidence and reasoning |
|---|---|---|
United Kingdom | Growing (inferred) | Consolidated revenue rose 32.6% in FY2026 while standalone fell, implying growth is coming through the UK subsidiary; India–UK CETA in force from 15 July 2026 grants zero-duty access for Indian leather goods and footwear |
India (domestic) | Declining/flat (standalone) | Standalone net sales fell from INR 68.66 Cr (FY2025) to INR 64.71 Cr (FY2026); Q3 FY2026 standalone net sales fell to INR 13.30 Cr from INR 21.75 Cr YoY |
United States | Headwind (industry) | US 50% tariff effective 27 Aug 2025; CRISIL expected Indian leather-sector revenue to decline 10–12% in FY2026. AKI's direct US exposure: not disclosed |
EU, Australia, UAE, South Africa | — | No data |
“—” = not publicly disclosed.
Share Price & Returns
| Period | Return | Source / note |
|---|---|---|
Last close | INR 5.81 (16 Oct 2026) | Screener.in |
1 month | -0.5% | ScanX |
6 months | +13.0% | ScanX |
1 year | -31.9% | ScanX (Screener: -31%) |
3 years | -29% CAGR (Screener); ≈-53.5% absolute (Anand Rathi, Sep 2026); -39.4% CAGR (IIFL, Aug 2026) | Sources differ by measurement date |
5 years | -92.8% absolute (ScanX); -23.6% CAGR (IIFL, Aug 2026); +19% CAGR (Screener) | Major discrepancy — likely due to differing adjustment for the 1:5 split and corporate actions and the SME-era base price; treat with caution |
52-week high / low | INR 8.87 / 3.72 | Screener.in, Oct 2026 |
Earlier 52-week high (as of May 2026) | INR 16.05 | Choice/Kotak |
Trading segment | NSE BE (trade-for-trade, no intraday netting) | Filings reference "Series: BE" |
Valuation Multiples
| Multiple | AKI India | Basis |
|---|---|---|
Market capitalisation (INR Cr) | 59.96 | 10.32 Cr shares |
Enterprise value (INR Cr) | 82.27 | Mcap + borrowings INR 27 Cr − cash INR 4.69 Cr (Mar 2026) |
P/E (TTM) | 19.8–20.1 | TTM PAT INR 2.98 Cr (Q2 FY2026–Q1 FY2027) |
P/B | 0.60 | Book value INR 9.72 |
EV/Sales (TTM) | 0.69 | TTM revenue INR 118.70 Cr |
EV/EBITDA (TTM, incl. other income) | 10.3 | TTM EBITDA incl. OI ≈INR 8.02 Cr |
Dividend yield | 0% | No dividends |
Peer multiple | Mirza International | — |
P/E | ≈50.4 (Tickertape; date of snapshot not specified) | — |
P/B | ≈1.10 | — |
Dividend History
| Year | Dividend per share (INR) |
|---|---|
FY2019–FY2026 | 0 (no dividend declared since listing) |
Credit Ratings
| Agency | Rating | Outlook | Date | Instruments |
|---|---|---|---|---|
Moody's | Not rated | — | — | — |
S&P | Not rated | — | — | — |
Fitch | Not rated | — | — | — |
CRISIL Ratings | B (long-term) / A4 (short-term), Issuer Not Cooperating | Stable | 30 Mar 2026 (also 22 Jan 2025, 30 Nov 2023) | INR 25 Cr bank facilities |
Debt Facilities
| Facility | Amount (INR Cr) | Tenor type |
|---|---|---|
Term loan | 6.0 | Long-term |
Packing credit | 6.0 | Short-term |
Post-shipment credit | 6.0 | Short-term |
Foreign letter of credit | 4.0 | Short-term (non-fund) |
Export funding | 2.4 | Short-term |
Proposed long-term facility | 0.5 | Long-term |
Cash credit | 0.1 | Short-term |
Total | 25.0 | ≈74% short-term |
Analyst Conclusions
Management guidance and consensus
No quantitative management guidance; no consensus. The only forward signals are (i) the ≈INR 30 Cr RPT approval with AKI UK for the coming period, indicating management expects UK-routed sales to keep growing; (ii) CWIP of INR 10 Cr awaiting capitalisation; and (iii) industry projections — CLE expects Indian leather and footwear exports to recover to USD 5.5 bn in FY2027, aided by FTAs.
Bull case
-
UK zero-duty access is a structural tailwind aimed squarely at AKI's model. With CETA in force since 15 July 2026, a UK subsidiary, and a heritage UK footwear partner, AKI is better positioned than most Kanpur micro-caps to capture the UK opportunity; consolidated revenue already grew 32.6% in FY2026 and 64.4% in Q1 FY2027.
-
Associate earnings are inflecting. Share of profit from AKI Castil Shoes LLP and associates rose from INR 0.02 Cr to INR 0.45 Cr YoY in Q1 FY2027; if sustained, this alone would annualise to ≈INR 1.8 Cr — roughly equal to FY2026 group PAT.
-
Deep discount to book. At P/B 0.60 and EV/Sales 0.69 with debt/equity of 0.27x, the market is pricing in significant value destruction; any demonstrable return to positive operating margins (FY2023 achieved 4.1%) could re-rate the stock sharply.
Bear case
-
The core business is loss-making at the operating level and burning cash. Operating EBITDA was -INR 3.31 Cr in FY2026; cumulative FCF over three years is ≈-INR 49 Cr; CCC has risen to 214 days. Reported profits rest on other income (INR 10.94 Cr) whose composition is undisclosed.
-
Governance and disclosure deficits are severe. CRISIL has classified the company as non-cooperative for three consecutive rating cycles; the independent-director bench was reconstituted three times in six months; a substantial SAST disclosure was filed eight months late; and revenue growth is increasingly routed through related parties, with an unexplained gap between standalone, subsidiary and consolidated revenue.
-
Value has been diluted, not compounded. Equity rose roughly six-fold after preferential issues while ROE fell to ≈2.3%; the shares are down ≈32% over one year and sharply over five years despite the capital raised.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | Nov 2026 | Operating margin sign; standalone vs consolidated divergence; associate share |
| FY2026 Annual Report deep-dive | Available now | Other-income breakdown; AKI UK revenue/assets; AKI Castil stake and financials; contingent liabilities; inventory ageing |
| Related-party flows with AKI UK | Ongoing vs ≈INR 30 Cr approval | Pricing, receivable days on intra-group sales |
| Solovair India launch / NPS JV disclosures | Undefined | Any commercial launch, volumes or capital commitments |
| Credit rating | Next CRISIL review (~2027) | Whether company resumes cooperation; any upgrade/withdrawal |
| Board stability | Ongoing | Absence of further independent-director churn; appointment of a regular chair |
| Transmission of late WTD's 5.59% stake | Pending | Any change in promoter-group composition |
| Exit from NSE BE (trade-for-trade) series | Periodic exchange review | Liquidity improvement |
| CWIP capitalisation | FY2027 | Capacity addition and its utilisation |
| US tariff and EU FTA developments | 2026–2027 | Sector demand and pricing |
Concluding analyst verdict
AKI India Limited is a genuine, three-decade-old leather manufacturer with real assets — an LWG Gold-rated tannery at Unnao, a heritage saddlery franchise, a UK subsidiary and a partnership with a respected British bootmaker — and it now sits in the path of one of the most favourable trade developments its industry has seen: zero-duty access to the UK from July 2026. On the surface, the numbers look like a growth story: consolidated revenue up 53% in three years to INR 107 Cr, Q1 FY2027 revenue up 64%, and a balance sheet de-levered to 0.27x debt/equity after successive equity raises.
Beneath the surface, the evidence is considerably less encouraging. The standalone Indian business shrank in FY2026; group operating EBITDA has been negative for two years; profit exists only because of an undisclosed other-income stream and, increasingly, equity-accounted associate earnings; and the company has burned roughly INR 49 Cr of free cash flow in three years while returns on a six-fold larger equity base have collapsed to ≈2%. The working-capital cycle of 214 days is unsustainable for a company with INR 4.7 Cr of cash. Layered on top are governance signals that institutional investors would treat as disqualifying: a credit-rating agency unable to obtain information for three years running, three board reconstitutions in six months, a materially late insider disclosure, and growth routed through related parties with a consolidation arithmetic that does not reconcile in the public record.
The 0.6x price-to-book multiple reflects these concerns rather than ignoring them. The investment case is therefore binary: it hinges on management demonstrating, through transparent disclosure, that UK- and JV-led growth is converting into positive operating cash flow. Until audited segment-level clarity on AKI UK and AKI Castil Shoes LLP is provided and core margins turn positive, the stock remains a high-risk, low-transparency micro-cap suitable only for speculative capital. Stance: Cautious / Avoid pending disclosure improvement.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / notes | Background |
|---|---|---|---|
Asad Kamal Iraqi | Founder & Chief Executive Officer; promoter | Founder; quoted as Founder & CEO in Oct 2023 | Leather industry entrepreneur; detailed CV not disclosed; age not disclosed |
Mohammad Ajwad | Managing Director; promoter group | MD as of 2026; chaired the 32nd AGM (23 Sep 2026) | Holds 2.91% after June 2025 warrant conversion (30,00,000 shares); designated partner of AKI Castil Shoes LLP per GST records; brother of Mohammad Asjad and Naba Fatima |
Mohammad Asjad | Non-Executive Director; promoter group | — | Brother of MD |
Naba Fatima | Additional Non-Executive, Non-Independent Director | From 7 Jul 2026 | Business management and leather-goods expertise; sister of MD |
Prabodh Sharma | Chief Financial Officer | — | — |
Divya Srivastava | Company Secretary & Compliance Officer | — | — |
Osama Anwar | Promoter (per CRISIL) | — | — |
Sameena (Samina) Asad Iraqi | Whole-Time Director (deceased 30 Dec 2025) | Director from Oct 2002 | Held 57,69,782 shares (5.59%) |
“—” = not publicly disclosed.
Board of Directors
| Name | Category | Committee roles |
|---|---|---|
Mohammad Ajwad | Managing Director (Executive, Promoter) | Member, Stakeholder Relationship Committee |
Mohammad Asjad | Non-Executive, Non-Independent (Promoter group) | — |
Naba Fatima | Additional Non-Executive, Non-Independent | — |
Abdul Rashid Khan | Additional Non-Executive, Independent | Chair of Audit, Nomination & Remuneration, and Stakeholder Relationship Committees; B.Com, LL.B.; 13+ years in law and finance |
Sarika Agarwal | Additional Non-Executive, Independent | Member, Audit; NRC; SRC; B.Com; entrepreneur |
Veqarul Amin | Additional Non-Executive, Independent | Member, Audit; NRC; qualified leather technologist with 35+ years' industry experience |
Board & Management Changes
| Date effective | Appointments | Resignations | Context |
|---|---|---|---|
9 Jan 2026 | Sarika Agarwal, Abdul Rashid Khan, Veqarul Amin (Independent) | Three existing directors (personal reasons; names not captured in summaries) | Followed death of WTD on 30 Dec 2025 |
8 Apr 2026 | Hardika Ladha (made committee chair), Nandish Shaileshbhai Jani (Independent) | Three independent directors (personal reasons) — understood to be the January appointees | Board reconstituted |
7 Jul 2026 | Sarika Agarwal, Abdul Rashid Khan, Veqarul Amin (re-appointed as Additional Independent Directors); Naba Fatima (Non-Independent) | Hardika Ladha (personal reasons, insufficient time); Nandish Shaileshbhai Jani | Committees reconstituted again |
Directors' Remuneration
| Director | Remuneration disclosed (INR Lakh) | Period |
|---|---|---|
Samina Asad Iraqi | 9.94 | Reporting half-year (H2 FY2026) |
Mohammad Ajwad | 10.93 | Reporting half-year (H2 FY2026) |
Mohammad Asjad | 5.50 | Reporting half-year (H2 FY2026) |
Shareholding Trend
| Shareholder category (%) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
Promoters & promoter group | 72.81 | 53.57 | 54.72 | 53.92 | 53.92 |
Foreign institutional investors | 0.00 | 3.50 | 2.71 | 0.00 | 0.00 |
Domestic institutional investors | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public / non-institutional | 27.20 | 42.93 | 42.58 | 46.08 | 46.08 |
Shareholder base | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
Number of shareholders | 150 | 4,967 | 12,164 | 14,378 | 15,250 |
Competitive Landscape
Competitors by Segment
| Product line | Named competitors | Notes |
|---|---|---|
Leather footwear exports (OEM/private label) | Mirza International (Kanpur; brands Thomas Crick, Oaktrak, Off The Hook London); Superhouse Ltd (Kanpur); Tata International (leather division); Farida Group; KH Exports | Mirza and Superhouse are Kanpur peers with far greater scale |
Domestic branded footwear | Bata India; Relaxo Footwears; Liberty Shoes; Khadim India; Metro Brands; Campus Activewear | Relevant to any Solovair India launch; scale differential is extreme |
Equestrian saddlery & harness | Superhouse Ltd (riding/saddlery division); numerous unlisted Kanpur exporters; global brands such as Weatherbeeta, Shires and Horseware (buyers as much as competitors) | Fragmented; AKI's heritage niche |
Finished leather / tanneries | Super Tannery Ltd; Amin Tannery Ltd; Mirza International (tannery); Superhouse (tannery) | Kanpur–Unnao cluster |
Leather goods & accessories | Bhartiya International; Zenith Exports; Welterman International; Hidesign (private) | Peer set per ScanX industry list |
Global footwear/heritage brands (via NPS) | Dr. Martens (historically linked to the same Northamptonshire bootmaking heritage), Red Wing, Grenson | Competitive reference for Solovair positioning |
Peer Comparison FY2026
| Metric | AKI India | Mirza International | Superhouse |
|---|---|---|---|
FY2026 revenue (INR Cr) | 107.33 (consolidated) | 516.23 (standalone); ≈527 (consolidated) | — |
Revenue growth (%) | 32.6 | -9.4 (standalone) | -12.0 (Q4 YoY) |
Profitability | Operating EBITDA margin -3.1%; net margin 1.8% | CRISIL cites weaker-than-expected FY2026 revenue and profitability | Q4 FY2026 net loss INR 1.29 Cr |
Export share | ≈55% (FY2025 standalone) | ≈85% of revenue; UK and US ≈64% (FY2025) | Significant (not quantified) |
Credit rating | CRISIL B/Stable/A4 (INC) | CRISIL BBB+/Negative/A2 (downgraded Apr 2026) | — |
Recent Developments
Layoffs/hiring, litigation, regulatory actions, guidance revisions:* None disclosed in this period.



